ProKidney Statistics
Total Valuation
ProKidney has a market cap or net worth of $487.43 million. The enterprise value is $234.65 million.
Market Cap | 487.43M |
Enterprise Value | 234.65M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ProKidney has 229.92 million shares outstanding. The number of shares has increased by 0.28% in one year.
Shares Outstanding | 229.92M |
Shares Change (YoY) | +0.28% |
Shares Change (QoQ) | +0.92% |
Owned by Insiders (%) | 22.95% |
Owned by Institutions (%) | 60.72% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.94
Current Ratio | 14.94 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2,455.00 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -7.70% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$217,595 |
Employee Count | 163 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ProKidney has paid $6.00 million in taxes.
Income Tax | 6.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.03% in the last 52 weeks. The beta is 1.29, so ProKidney's price volatility has been higher than the market average.
Beta (1Y) | 1.29 |
52-Week Price Change | -79.03% |
50-Day Moving Average | 1.72 |
200-Day Moving Average | 3.95 |
Relative Strength Index (RSI) | 51.93 |
Average Volume (30 Days) | 713,922 |
Short Selling Information
The latest short interest is 11.56 million, so 5.03% of the outstanding shares have been sold short.
Short Interest | 11.56M |
Short Previous Month | 13.98M |
Short % of Shares Out | 5.03% |
Short % of Float | n/a |
Short Ratio (days to cover) | 18.53 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -151.52M |
Pretax Income | -29.47M |
Net Income | -35.47M |
EBITDA | -25.61M |
EBIT | -29.46M |
Earnings Per Share (EPS) | -$0.57 |
Balance Sheet
The company has $362.95 million in cash and $4.41 million in debt, giving a net cash position of $358.54 million or $1.56 per share.
Cash & Cash Equivalents | 362.95M |
Total Debt | 4.41M |
Net Cash | 358.54M |
Net Cash Per Share | $1.56 |
Equity / Book Value | -1.10B |
Book Value Per Share | -4.80 |
Working Capital | 349.11M |
Cash Flow
In the last 12 months, operating cash flow was -$90.07 million and capital expenditures -$34.20 million, giving a free cash flow of -$124.27 million.
Operating Cash Flow | -90.07M |
Capital Expenditures | -34.20M |
Free Cash Flow | -124.27M |
FCF Per Share | -$2.01 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ProKidney does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.28% |
Shareholder Yield | -0.28% |
Earnings Yield | -5.98% |
FCF Yield | -20.95% |
Analyst Forecast
The average price target for ProKidney is $7.00, which is 230.19% higher than the current price. The consensus rating is "Buy".
Price Target | $7.00 |
Price Target Difference | 230.19% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | Jul 12, 2022 |
Split Type | n/a |
Split Ratio | 1:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |